日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry

抗CD20疗法和S1P受体调节剂在晚发性多发性硬化症中的疗效比较:来自MSBase注册库的真实世界证据

Surcinelli, Andrea; Kalincik, Tomas; Roos, Izanne; D'Amico, Emanuele; Lechner-Scott, Jeannette; Ozakbas, Serkan; Hradilek, Pavel; Horáková, Dana; Vachova, Marta; Panzera, Ivan; Ruzza, Stefano; Piscaglia, Maria Grazia; Gerlach, Oliver; Meca-Lallana, Jose Eustasio; Valero-López, Gabriel; Kermode, Allan G; Fabis-Pedrini, Marzena J; Prevost, Julie; Ampapa, Radek; Hodgkinson, Suzanne; Grand'Maison, Francois; Khoury, Samia J; John, Nevin A; Peterka, Marek; Houskova, Jana; Recmanova, Eva; Rous, Zuzana; Shaygannejad, Vahid; Alroughani, Raed; Kuhle, Jens; Jakob, Gregor Brecl; Grammond, Pierre; Patti, Francesco; Van der Walt, Anneke; Butzkueven, Helmut; Foschi, Matteo

Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry

克拉屈滨作为多发性硬化症升级治疗策略的实际疗效:来自捷克全国ReMuS注册研究的启示

Potuznik, Pavel; Drahota, Jiri; Horakova, Dana; Peterka, Marek; Mazouchova, Aneta; Matyas, David; Pavelek, Zbysek; Vachova, Marta; Recmanova, Eva; Stetkarova, Ivana; Libertinova, Jana; Mares, Jan; Stourac, Pavel; Grunermelova, Marketa; Martinkova, Alena; Adamkova, Jana; Hradilek, Pavel; Ampapa, Radek; Dufek, Michal; Kubala Havrdova, Eva; Stastna, Dominika

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia

多发性硬化症、视神经脊髓炎谱系障碍和新冠肺炎:捷克的疫情之年

Stastna, Dominika; Menkyova, Ingrid; Drahota, Jiri; Mazouchova, Aneta; Adamkova, Jana; Ampapa, Radek; Grunermelova, Marketa; Peterka, Marek; Recmanova, Eva; Rockova, Petra; Rous, Matous; Stetkarova, Ivana; Valis, Martin; Vachova, Marta; Woznicova, Ivana; Horakova, Dana